Core Viewpoint - The announcement reveals that Guoshou Chengda, a pre-IPO shareholder of Maipu Medical, plans to reduce its stake in the company by approximately 2.9958% through both centralized bidding and block trading from July 14 to August 15, 2025 [1] Summary by Category Shareholder Actions - Guoshou Chengda will reduce its holdings by a total of 1,995,582 shares, which represents 2.9958% of the total share capital of Maipu Medical [1] - The reduction will occur in two phases: centralized bidding from July 14 to July 22, 2025, with an average selling price of 61.53 CNY per share for 665,194 shares (0.9986% of total share capital) [1] - The block trading phase will take place from July 15 to August 15, 2025, with an average selling price of 65.35 CNY per share for 1,330,388 shares (1.9972% of total share capital) [1] Ownership Changes - Following the reduction, Guoshou Chengda's shareholding in Maipu Medical will decrease from 3,267,436 shares to 1,271,854 shares [1] - The ownership percentage will drop from 4.9120% to 1.9093% of the total share capital [1]
迈普医学：首发前股东国寿成达减持2.9958%股份